SetPoint Medical Funding: $220M Raised, Series D (2025)
SetPoint Medical is a Biotech company based in Thousand Oaks, California. It has raised $220M in total funding. Latest round: Series D.
SetPoint Medical funding overview
SetPoint Medical is a Biotech company based in Thousand Oaks, California. SetPoint Medical has raised $220M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in August 2025. The round record for SetPoint Medical runs through 2025; nothing later has been disclosed. Investors on record include Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest, New Enterprise Associates (NEA) and 12 others. 18 distinct backers are named across the disclosed rounds.
SetPoint Medical at a glance
Total raised
$220M
Latest round
Series D
Latest round date
August 2025
Industry
Biotech
Headquarters
Thousand Oaks, California
Notable investors
Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest, New Enterprise Associates (NEA), Viking Global Investors, Action Potential Venture Capital
Frequently asked about SetPoint Medical funding
How much has SetPoint Medical raised?
SetPoint Medical has raised $220M in total disclosed funding across the rounds on record.
Who has invested in SetPoint Medical?
Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest, New Enterprise Associates (NEA) are named among the investors backing SetPoint Medical.
What was the latest SetPoint Medical funding round?
The most recent disclosed round is a Series D, announced in August 2025.
Where is SetPoint Medical based?
SetPoint Medical is based in Thousand Oaks, California.
What sector does SetPoint Medical operate in?
SetPoint Medical is tracked under Biotech from Thousand Oaks, California, with $220M in disclosed funding.
When did SetPoint Medical last raise?
The last disclosed SetPoint Medical round closed in August 2025 at Series D.
SetPoint Medical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Thousand Oaks below to benchmark round size and investor mix.
